Delray Medical Center is the first hospital in Florida to acquire the Viz Vascular Suite. This is a comprehensive software its vascular care team can use to detect disease, optimize workflow, and coordinate care. The Viz Vascular Suite uses artificial intelligence (AI) to automatically detect suspected pulmonary embolism, right/left ventricle dilation, aortic dissection, and abdominal aortic aneurysm[1] to facilitate informed and efficient treatment decisions.
“Being able to identify a patient with a serious vascular condition, such as an abdominal aortic aneurysm, early – before they have an emergency, is a game changer and literally a lifesaver,” said Dr. Joseph Ricotta, professor of surgery and program director of the vascular surgery fellowship at Florida Atlantic University College of Medicine, and national medical director of vascular surgery and endovascular therapy at Tenet Healthcare. “For example, there are roughly 1.5 million abdominal aortic aneurysms in the US per year; however, only 10 percent get diagnosed and treated. We don’t often find out about them until it’s too late and, even then, there’s only a 25 percent chance of living through a ruptured aortic aneurysm. From my experience as an early adopter of this technology, the Viz Vascular Suite will help enhance screening and coordinate care across my vascular team.”
The Viz Vascular Suite is designed to automatically analyze imaging and data and, in turn, eliminate futile patient transfers between departments and decrease the time patients spend in the emergency department. Using the Viz.ai platform, care can be coordinated for any vascular pathology, and managed remotely within a hub and spoke network, which expedites diagnosis and treatment. It also aids Delray Medical Center in activating its Pulmonary Embolism Response Team (PERT), which is a multidisciplinary team that rapidly assesses and provides treatment for patients with acute pulmonary embolism.
















